DHCR7

gene product
SLOS
This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS); a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by cognitive disability, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Aug 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
157 antibodies from 22 providers.

Antibody properties

General

Applications

or Cancel
Antibody
GeneTex
3 antibodies
Biorbyt
14 antibodies
NovoPro Bioscience Inc.
2 antibodies
Abgent
1 antibody
Acris Antibodies GmbH
1 antibody
LifeSpan BioSciences, Inc.
37 antibodies
Invitrogen Antibodies
4 antibodies
St John's Laboratory
2 antibodies
Aviva Systems Biology
1 antibody
ProSci
1 antibody
antibodies-online
43 antibodies
Novus Biologicals
2 antibodies
Atlas Antibodies
1 antibody
MyBioSource
5 antibodies
Creative Biolabs
3 antibodies
Abnova Corporation
2 antibodies
OriGene
1 antibody
United States Biological
13 antibodies
Bethyl Laboratories
1 antibody
Creative Diagnostics
2 antibodies
Sigma-Aldrich
3 antibodies